These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Chemotherapy of leprosy. II. Compounds structurally related to 4, 4'-diaminodiphenylsulfone. BERTI FA; ZITI LM; PEREGO C; RZEPPA HW; RIECKMANN BH; RAPP OP Rev Bras Leprol; 1952; 20(3-4):197-208. PubMed ID: 13047727 [No Abstract] [Full Text] [Related]
5. The chemotherapy of leprosy: late results of treatment with sulphone, and with thiosemicarbazone. LOWE J Lancet; 1954 Nov; 267(6847):1065-8. PubMed ID: 13213118 [No Abstract] [Full Text] [Related]
6. [Use of isopropyl sulfones in leprosy. II. Therapeutic results]. FLOCH H; DEHEZ F Bull Soc Pathol Exot Filiales; 1956; 49(6):1093-7. PubMed ID: 13426727 [No Abstract] [Full Text] [Related]
7. [Sulfones by treatment of leprosy]. MARIANO J; DINIZ O; AZEVEDO JG; STANCIOLI J; PEREIRA PC Arq Min Leprol; 1953 Oct; 13(4):308-18. PubMed ID: 13159687 [No Abstract] [Full Text] [Related]
9. [Depot chemotherapy in the leprosy campaign in French West Africa; diaminodiphenylsulfone suspensions for bi-monthly injections]. LAVIRON P; LAURET L; JARDIN C Bull Soc Pathol Exot Filiales; 1954; 47(1):127-39. PubMed ID: 13182485 [No Abstract] [Full Text] [Related]
10. [Use of isopropyl sulfones in leprosy. I. Mechanism of action]. FLOCH H; DEHEZ F Bull Soc Pathol Exot Filiales; 1956; 49(6):1089-92. PubMed ID: 13426726 [No Abstract] [Full Text] [Related]
11. [Intramuscular sulfones in the treatment of leprosy]. MONTESTRUC E; LE SAGET M; BERDONNEAU R Arch Inst Pasteur Martinique; 1955; 8(1-2):17-31. PubMed ID: 13239227 [No Abstract] [Full Text] [Related]
12. [The sulfones and the thiosemicarbazones in leprosy]. BASSET A Therapie; 1951; 6(4 bis):311-23. PubMed ID: 14922305 [No Abstract] [Full Text] [Related]
13. [Some results of leprosy therapy with sulfones in French Guiana]. FLOCH H; NOMDEDEU G Med Trop (Mars); 1951; 11(6):921-7. PubMed ID: 14918690 [No Abstract] [Full Text] [Related]
14. [Intramuscular administration of sulfones in the treatment of leprosy]. MONTESTRUC E; LE SAGET M; BERDONNEAU R Bull Soc Pathol Exot Filiales; 1955; 48(1):64-78. PubMed ID: 13240401 [No Abstract] [Full Text] [Related]
15. [Importance of the study of sulfones in blood in sulfone therapy of leprosy]. FLOCH H Bull Soc Pathol Exot Filiales; 1955; 48(3):396-402. PubMed ID: 13304618 [No Abstract] [Full Text] [Related]
16. [Weekly depot injections of soluble sulfones (diethyldiaminodiphenylsulfone and succinyldiaminodiphenylsulfone) in leprosy therapy]. FLOCH H; GELARD AM Bull Soc Pathol Exot Filiales; 1954; 47(5):646-52. PubMed ID: 14364159 [No Abstract] [Full Text] [Related]
17. Blood and urine concentrations of free and hydrolyzed sulfones in leprosy patients under treatment. SISTER H ROSS ; GEMAR F Int J Lepr; 1951; 19(2):153-60. PubMed ID: 14873382 [No Abstract] [Full Text] [Related]
18. [Importance of retard-action chemotherapy in the antileprosy campaign]. JARDIN C; KERBASTARD P; LAURET L; LAVIRON P Int J Lepr; 1956; 24(2):138-44. PubMed ID: 13376141 [No Abstract] [Full Text] [Related]
19. [Sulfone therapy in leprosy]. FLOCH H; DESTOMBES P Arq Min Leprol; 1951 Jan; 11(1):11-5. PubMed ID: 14869251 [No Abstract] [Full Text] [Related]
20. [Remarks on sulfone therapy of leprosy]. FLOCH H Bull Soc Pathol Exot Filiales; 1952; 45(6):757-63. PubMed ID: 13032766 [No Abstract] [Full Text] [Related] [Next] [New Search]